Latest Prenatal diagnosis Stories
NEW YORK, April 6, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has signed an exclusive agreement with AdnaGen, a wholly-owned subsidiary of Alere, Inc., to license specific antibodies.
The Update on Prenatal Diagnosis and Treatment of Fetal Anomalies conference occurs in Philadelphia today through March 19 Philadelphia, PA (Vocus/PRWEB) March 16, 2011 An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects.
PHILADELPHIA, March 16, 2011 /PRNewswire-USNewswire/ -- An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects.
Researchers from Cyprus report that a simple blood test can predict whether a baby is likely to have Down Syndrome.
MEDFORD, Mass., Feb.
In 1980 in the United States, approximately 4.5% of all pregnant women were of advanced maternal age.
Performing delicate surgery in the womb, months before birth, can substantially improve outcomes for children with a common, disabling birth defect of the spine.
SAN DIEGO, Feb.
A test that uses the latest DNA technology to analyze genetic components in a pregnant woman's blood could predict Down's syndrome in unborn babies, according to new research.
When prenatal diagnosis detects the severe heart defect hypoplastic left heart syndrome (HLHS) in a fetus, a comprehensive prenatal evaluation is important to provide parents an accurate prognosis.
- A woman chauffeur.
- A woman who operates an automobile.